The effect of storage time and freeze-thaw cycles on the stability of serum samples by Serap Cuhadar et al.
Biochemia Medica 2013;23(1):70–7  http://dx.doi.org/10.11613/BM.2013.009
70
Abstract
Introduction: Optimal storage of serum specimens in central laboratories for a long period for multicenter reference interval studies, or epidemi-
ologic studies remains to be determined. We aimed to examine the analytical stability of chemistry analytes following numerous freeze-thaw and 
long term storage.
Materials and methods: Serum samples were obtained from 15 patients. Following baseline measurement, sera of each subject were aliquoted 
and stored at -20 ˚C for two experiments. A group of sera were kept frozen for up to 1, 2 and 3 months and then analyzed for stability. The other 
experiment consisted of one to ten times of freeze and thaw cycles. Total of 17 chemistry analytes were assayed at each time point. The results were 
compared with those obtained from the initial analysis of fresh samples. Median or mean changes from baseline (T0) concentrations were evaluated 
both statistically and clinically according to the desirable bias.
Results: Of the analytes studied, aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), gamma-glutamyl tran-
sferase (GGT), direct bilirubin, glucose, creatinine, cholesterol, triglycerides, high density lipoprotein (HDL) were stable in all conditions. Blood urea 
nitrogen (BUN), uric acid, total protein, albumin, total bilirubin, calcium, lactate dehydrogenase (LD) were changed signifi cantly (P < 0.005).
Conclusions: As a result, common clinical chemistry analytes, with considering the variability of unstable analytes, showed adequote stability after 
3 months of storage in sera at -20 °C, or up to ten times of freeze-thaw cycle. All the same, such analysis can only be performed for exceptional cases, 
and this should be taken into account while planning studies.
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Optimal storage of serum specimens in biobanks 
for a long time for multicenter reference interval 
studies, or epidemiologic studies remains to be 
determined.
Specimens shipped from multicenter laboratories 
are usually stored in a central laboratory for further 
analysis. Parameters that may vary across collec-
tions include; i) delays in shipping frozen samples; 
ii) power cut or voltage fl uctuations of the freez-
ers; and iii) using frost-free freezer that goes 
through numerous defrost cycles, which may re-
sult in loss of some analytes.
Pre-analytical phase is the most critical part of the 
total analytical process which has impacts on pa-
tient reports in clinical chemistry testing (1). It is 
possible in practice to reanalyze the samples 
stored to confi rm the previous results or to per-
form additional analysis, however the stability of 
the analytes must be assured before giving results, 
or before establishing new investigations. Further-
more, analyzing unsuitable samples often cause 
high cost expenditures and enlargement of total 
testing process.
Manufacturers allow the usage of sera stored fro-
zen and thawed only for once, and advise to dis-
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perse sera into the single usage aliquots before 
freezing. However, the number and volume of the 
aliquots must be taken into account regarding the 
handling and freezer space costs while planning 
the studies.
There are various studies examined how storage 
conditions aff ected the stability of various serum 
components (2-5). However, there is less informa-
tion on the stability of commonly used chemistry 
analytes in human sera.
The present study examined the stability of 17 rou-
tine chemistry analytes in sera after storing at a 




This study included fi fteen out-patients attending 
the clinics of our hospital. The specimens collected 
from each patient were for the laboratory testing 
ordered by the physician. No additional blood was 
taken from the subjects. All were informed for the 
study and signed the informed consent. The pro-
cedures were in accordance with the guidelines of 
the Helsinki Declaration on human experimenta-
tion.
Study design
Fasting venous blood (totally 25.5 cc blood) was 
collected in the morning into three 8.5 mL plastic 
evacuated tubes (BD Vacutainer Systems, Becton-
Dickinson, Plymouth, UK). The sample tubes were 
left in upright position for 30 min at room temper-
ature for complete clot formation. All were then 
centrifuged at 1800 x g for 10 minutes (according 
to the instruction of the tube manufacturer). Serum 
samples were checked visually for hemolysis and li-
pemia for possible interferences (6,7). Sera of each 
subject were pooled into a plain tube, and were al-
iquoted into 1.5-mL Eppendorf (Eppendorf, Milano, 
Italy) tubes. Composing of 13 aliquots for each pa-
tient (three for storage, 10 for freeze-thaw), remain-
ing sera were used for the patients’ requested tests. 
Following baseline measurement (T0), all were kept 
frozen until analysis for two experiments below:
Ten samples of each subject were frozen at -20 • 
°C. After 24 hours, all frozen sera in the Eppen-
dorf tubes of each patient were thawed at room 
temperature for approximately 1 h until com-
pletely thawed, and then mixed properly with au-
tomatic pipettes before analysis (freeze-thaw 1).
Samples were immediately re-frozen at -20 °C • 
for the next study day. This cycle was repeated 
for ten consecutive days (T1d, T2d, T3d, T4d, T5d, T6d, 
T7d, T8d, T9d, T10d) to yield freeze- thaw process-
ing.
A group of sera were stored frozen at -20 °C for • 
up to 1, 2 and 3 months, and then analyzed for 
stability in singleton at three time intervals (T1m, 
T2m, T3m).
Samples stored at -20 °C were kept in a freezer 
equipped with a temperature recorder (Figure 1).
Methods
Assays were performed on the Abbott Aeroset an-
alyzer (Abbott, Wiesbaden, Germany) with Abbott 
reagents at the Department of Clinical Biochemis-
try Laboratory of Ataturk Training and Research 
FIGURE 1. The temperature graph of the freezer during the 
freeze-thaw period.
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Analyte Method Intra-assay CV (%) Inter-assay CV (%)
Albumin (g/L) Bromcresol green 2.0 1.4
ALT (U/L) UV without P5P 0.7 2.8
AST (U/L) UV without P5P 0.5 1.5
Bilirubin, direct (μmol/L) Diazotization 1.7 3.1
Bilirubin, total (μmol/L) Diazonium ion 0.5 0.9
BUN (mmol/L) Urease, UV 1.6 3.5
Calcium (mmol/L) Arsenazo III 0.4 1.0
Cholesterol (mmol/L) CHOD-PAP 0.6 0.9
Creatinine (μmol/L) Alkaline picrate 0.7 0.4
CK (U/L) UV-NAC activated 0.3 1.0
Glucose (mmol/L) Hexokinase 0.7 0.8
GGT (U/L) Gamma-glutamyl-carboxyl nitroanilide 0.5 0.8
HDL (mmol/L) Direct, non-immunologic 5.1 3.6
LD (U/L) Lactate-pyruvate, UV 0.8 1.6
Protein, total (g/L) Biuret 1.3 1.1
Triglyceride (mmol/L) GPO-PAP 1.0 1.4
Uric acid (μmol/L) Uricase, PAP 0.8 0.6
Inter-assay variation was assessed from totally 20 determinations (with 2 determinations each day) on 10 consecutive 
study days, and intra-assay variation was assessed from 8 determinations, measured on a single assay.
ALT - alanine aminotransferase; AST - aspartate aminotransferase; BUN - blood urea nitrogen; CK - creatine kinase; GGT 
- gamma-glutamyl transferase; HDL - high density lipoprotein; LD - lactate dehydrogenase.
Hospital in Izmir, Turkey. The following biochemi-
cal constituents were assayed:
metabolites: BUN (blood urea nitrogen), calci-• 
um, creatinine, direct bilirubin, glucose, total bi-
lirubin, uric acid;
proteins: total protein, albumin;• 
lipids: triglycerides, cholesterol, HDL (high den-• 
sity lipoprotein);
enzymes: ALT (alanine aminotransferase), AST • 
(aspartate aminotransferase), CK (creatine ki-
nase), GGT (gamma-glutamyl transferase), LD 
(lactate dehydrogenase).
Intra-assay and inter-assay CV’s were performed 
with pooled patient sera diff erent from the study 
subjects (Table 1). Inter-assay variation was as-
sessed from 20 determinations (with 2 aliquots 
each day) on ten consecutive study days, and in-
tra-assay variation was calculated from eight se-
TABLE 1. Methods, intra and inter-assay coeffi  cient of variations.
quental determinations obtained from the fi rst 
day of the study period.
Quality control was performed each day before 
studying aliquots with two levels of control mate-
rials (Bio-Rad Laboratories, Milano, Italy).
Statistical analysis
Stabilities of analytes after freeze thaw cycles and 
after storage were assessed by percentage change 
from T0 for paired groups (T0 -T1d, T0 -T2d, etc. and T0 
- T1m, T0 -T2m, etc). Bias was calculated by the formu-
la:
[(CX-C1)/C1)] × 100%
C1: the mean or median of the T0 sample;
CX: the mean or median of the experimented sam-
ple.
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Median or mean changes from T0 concentrations 
were evaluated both statistically and clinically ac-
cording to the desirable bias taken from the West-
gard QC (8), which was fi rst published at 1999 and 
updated at 2012 by Ricos et al.
The distribution of the variables was determined 
using Shapiro-Wilk normality test.
In normally distributed groups, results were pre-
sented as mean ± standard deviation. The signifi -
cant diff erences from T0 value were determined by 
Paired samples t-test. For non-Gaussian groups, 
median variations from T0 was determined by non-
parametric Friedman test and Wilcoxon signed 
rank test using licensed statistical package for Win-
dows, Version 15.0, SPSS Inc. (Chicago, IL, USA). P 
value < 0.005 (0.05/11 = 0.0045) for freeze-thaw cy-
cles and P < 0.013 (0.05/4 = 0.0125) for storage pe-
riod were considered statistically signifi cant ac-
cording to Bonferroni correction for multiple com-
parisons.
Results
The results and variations for two experiments are 
presented in table 2 and fi gures 2 and 3.
Freeze-thaw cycles
After samples had been frozen and thawed up to 
ten times, there were no statistically signifi cant dif-
ferences for AST, ALT, GGT, cholesterol, glucose, 
creatinine, direct bilirubin and HDL levels.
Statistically signifi cant changes were not clinically 
signifi cant for triglyceride and CK. Sera should not 
go through more than one freeze-thaw cycle for 
total bilirubin (P < 0.005). Among the analytes 
studied, total protein and uric acid were found as 
the least stable tests (Table 2). Albumin concentra-
tion was not altered statistically as long as seven 
freeze-thaw cycles and increased afterwards. BUN 
and calcium were stable up to three freeze-thaw 
and LD was found as stable for fi ve cycles evaluat-
ing together the signifi cance clinically and statisti-
cally. Statistically signifi cant changes were marked 
in bold in table 2.
FIGURE 3. Percentage change in concentrations during storage 
for 1–3 months at -20 °C.
Alb - albumin; ALT - alanine aminotransferase; AST – aspartate 
aminotransferase; BUN - blood urea nitrogen; Ca - calcium; CK - 
creatine kinase; Chol - cholesterol; D BIL - direct bilirubin; GGT - 
gamma-glutamyl transferase; HDL - high density lipoprotein; LD 
- lactate dehydrogenase; T BIL - total bilirubin; TG - triglyceride; 
UA - uric acid; T0 - baseline, T1d-10d - 1-10 corresponding days of 
freeze-thaw cycle, T1m-3m – corresponding months of storage.
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Storage at -20 °C
Except from albumin, total protein and BUN levels, 
there were no signifi cant variations for sera stored 
until 3 months. Statistical and clinical signifi cances 
were evaluated for all analytes.
Albumin and total protein concentration changed 
signifi cantly (P < 0.013) after 3 months of storage. 
BUN concentration showed variability during stor-
age (Table 2).
Discussion
This study examined the storage and repeated 
freeze thaw eff ects on chemistry analytes pre-ana-
lytically. According to our fi ndings, 14 analytes af-
ter storage and 10 analytes following freeze-thaw 
cycles showed clinically equivalent results.
In a comprehensive study by Jackson et al. (9) clini-
cally negligible biases were obtained in most of 
the routine clinical chemistry parameters follow-
ing repeatedly freeze-thaw cycles between 0 to 24 
hour. Cray et al. (10), experimented the storage sta-
bility of rat sera at -20 °C for glucose, BUN, calcium, 
total protein, albumin, AST, ALT, LD and CK when 
stored in nonfrost freezer up to 90 days. In agree-
ment with Jackson and Cray (9,10), we found glu-
cose concentrations as stable through the whole 
experiment. However in a study (11), glucose con-
centrations were found as increased from 11.8 to 
14.0% in human serum refrozen and thawn even 
once.
Protein stability is problematic. Fast freezing with 
slow thawing resulted in severe damage in pro-
teins, accordingly, slow freezing and fast thawing 
process is advised to prevent protein denaturation 
in aqueous solutions (12). In human fl uids, long 
time storage in freezer is advised instead of thaw-
ing samples repeatedly (13). The variations for al-
bumin and total protein were found as outside the 
desirable bias (8) during storage and freezing 
thawing cycles in this study, however the bias 
could not be explained by denaturation, as the 
concentrations were measured as increased.
In accordance with the current study, Paltiel and 
Comstock et al. (14,15) reported the stability of se-
rum cholesterol and triglyceride concentrations 
during storage in freezer and following freeze 
thaw cycles. The present study confi rms the fi nd-
ings of Beekhof et al. (16), who found a good sta-
bility of HDL up to 6 months of storage at -20 °C.
Paltiel et al. (14), subjected the human plasma sam-
ples to several freeze thaw cycles after storage at 
-80 °C and AST activity was determined as stable 
within the 10-15 freeze-thaw cycles. Throughout 
the multiple time points we assessed, all of the en-
zyme levels measured were biased insignifi cantly, 
except from LD activity.
Our results indicate an appreciable increase in BUN 
values over time, however BUN instability has been 
observed in a recent study as a large percentage 
decrease (15.6% average) when samples were 
stored at -20 °C (17).
The estimated percentage change in uric acid con-
centrations per freeze thaw cycle showed an in-
creasing trend over time as this analyte was dem-
onstrated as unstable after 48 hours in human se-
rum stored at -4 °C in a recent study (18).
In the present study, time dependent decreases 
during storage and within the 10 times of freezing 
cycle were statistically insignifi cant for creatinine 
assay.
Total bilirubin concentration was found as stable 
up to three months of storage at -20 °C, unlike to a 
study in which authors demonstrated decreases 
both at -20 °C and at -80 °C (19) after storage even 
for two weeks. Although total bilirubin concentra-
tions signifi cantly decreased due to freeze-thaw 
cycles in the present study, practically serum is not 
stored for this analyte assay for future use in labo-
ratories, considering its photo-sensitivity. In the 
CALIPER study (17), similar to our study, signifi cant 
negative slope was observed for total bilirubin in 
samples stored at -20 °C with a low baseline con-
centration for a few months, and that relative large 
bias was attributed to the low baseline analyte 
concentrations.
The limitation of this study is that the results are 
based on small patient group size. Secondly, all 
time measurements were done once because of 
economical reasons. The pH of the samples was 
not measured to evaluate the possible bacterial 
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growth in the specimen which may cause errone-
ously elevated results for urea. Determinations 
were done with the defi ned analyzer with its origi-
nal reagents. Therefore, these results might not be 
universally reproducible with other testing sys-
tems.
As a result, common clinical chemistry analytes, 
with considering the variability of unstable ana-
lytes, showed adequote stability after 3 months of 
storage in sera at -20 °C, or up to ten times of 
freeze-thaw cycle. All the same, such analysis can 
only be performed for exceptional cases, and re-
sults must be interpreted with great attention.
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